Qiagen N.V. (QGEN): Price and Financial Metrics

Qiagen N.V. (QGEN): $49.54

0.15 (+0.30%)

POWR Rating

Component Grades














  • QGEN scores best on the Quality dimension, with a Quality rank ahead of 91.15% of US stocks.
  • QGEN's strongest trending metric is Momentum; it's been moving down over the last 177 days.
  • QGEN's current lowest rank is in the Momentum metric (where it is better than 1.11% of US stocks).

QGEN Stock Summary

  • QIAGEN NV's market capitalization of $11,246,103,000 is ahead of 84.36% of US-listed equities.
  • Revenue growth over the past 12 months for QIAGEN NV comes in at -0.65%, a number that bests just 23.19% of the US stocks we're tracking.
  • The volatility of QIAGEN NV's share price is greater than that of just 8.14% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to QIAGEN NV, a group of peers worth examining would be HOLX, LOGI, LFUS, CTS, and PKI.
  • Visit QGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.qiagen.com.

QGEN Valuation Summary

  • In comparison to the median Healthcare stock, QGEN's price/earnings ratio is 3.17% higher, now standing at 22.8.
  • Over the past 243 months, QGEN's price/sales ratio has gone up 2.

Below are key valuation metrics over time for QGEN.

Stock Date P/S P/B P/E EV/EBIT
QGEN 2023-01-30 5.0 3.3 22.8 18.7
QGEN 2023-01-27 5.0 3.4 23.0 18.8
QGEN 2023-01-26 5.1 3.4 23.3 19.0
QGEN 2023-01-25 5.2 3.4 23.5 19.2
QGEN 2023-01-24 5.1 3.4 23.4 19.1
QGEN 2023-01-23 5.2 3.5 23.6 19.3

QGEN Growth Metrics

    The 4 year net cashflow from operations growth rate now stands at -14.46%.
  • Its 2 year cash and equivalents growth rate is now at 16.43%.
  • Its 2 year revenue growth rate is now at 49.23%.
Over the past 30 months, QGEN's revenue has gone up $676,065,000.

The table below shows QGEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 2,225.932 826.394 488.008
2022-06-30 2,261.046 733.338 514.298
2022-06-30 2,261.046 733.338 514.298
2022-03-31 2,312.842 717.784 538.688
2022-03-31 2,312.842 717.374 538.688
2021-12-31 2,251.657 639.001 512.599

QGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • QGEN has a Quality Grade of B, ranking ahead of 79.35% of graded US stocks.
  • QGEN's asset turnover comes in at 0.375 -- ranking 125th of 682 Pharmaceutical Products stocks.
  • ALNY, TXMD, and CASI are the stocks whose asset turnover ratios are most correlated with QGEN.

The table below shows QGEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.375 0.655 0.192
2021-03-31 0.363 0.658 0.199
2020-12-31 0.338 0.659 0.176
2020-12-31 0.338 0.659 0.176
2020-09-30 0.319 0.665 0.122
2020-09-30 0.319 0.665 0.122

QGEN Stock Price Chart Interactive Chart >

Price chart for QGEN

QGEN Price/Volume Stats

Current price $49.54 52-week high $51.30
Prev. close $49.39 52-week low $40.38
Day low $49.11 Volume 788,200
Day high $49.74 Avg. volume 622,735
50-day MA $49.66 Dividend yield N/A
200-day MA $46.67 Market Cap 11.25B

Qiagen N.V. (QGEN) Company Bio

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

QGEN Latest News Stream

Event/Time News Detail
Loading, please wait...

QGEN Latest Social Stream

Loading social stream, please wait...

View Full QGEN Social Stream

Latest QGEN News From Around the Web

Below are the latest news stories about QIAGEN NV that investors may wish to consider to help them evaluate QGEN as an investment opportunity.

Genetic Technologies Shares Jump After Strategic Alliance With Qiagen

Genetic Technologies Limited (NASDAQ: GENE ) agreed to form a strategic alliance with Qiagen NV (NYSE: QGEN ) to establish and develop a ''Centre of Excellence facility in Australia. Qiagen will support the improvement of GTG capabilities through software, hardware, consumable and technical solutions. Genetic Technologies CEO Simon Morriss said it was an exciting opportunity for the company. "We are … Full story available on Benzinga.com

Benzinga | February 1, 2023

Why TransCode Therapeutics Shares Are Trading Higher By 42%; Here Are 20 Stocks Moving Premarket

Gainers Motorsport Games Inc. (NASDAQ: MSGM ) shares rose 121% to $47.48 in pre-market trading after jumping over 710% on Tuesday. The company announced a debt-for-equity exchange with Motorsport Network. Also, Investor Mike Zoi reported purchase of 338,983 shares of Motorsport Games at an average price of $2.95 per share in Form 4 Filing. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX ) shares rose 67% to $2.77 in pre-market trading after gaining around 10% on Tuesday. TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) rose 42.5% to $1.07 in pre-market trading after the company reported preclinical results with immunotherapy candidate TTX-RIGA in melanoma. Wearable Devices Ltd. (NASDAQ: WLDS ) shares rose 39.2% to $1.10 in pre-market trading after gaining around 20% on Tuesday. Genetic Technologi...

Benzinga | February 1, 2023

Will Qiagen (QGEN) Beat Estimates Again in Its Next Earnings Report?

Qiagen (QGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | February 1, 2023

Qiagen (QGEN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | January 31, 2023

Qiagen Mulls Stake Sale in Bioinformatics Unit; To Release Q4 Numbers on Feb 7

Sample technology and solutions provider Qiagen (NYSE:QGEN) is mulling offloading a minority stake in its bioinformatics outfit, according to Bloom…

TipRanks | January 30, 2023

Read More 'QGEN' Stories Here

QGEN Price Returns

1-mo -0.92%
3-mo 18.15%
6-mo 2.10%
1-year -0.46%
3-year 38.57%
5-year 53.00%
YTD -0.66%
2022 -10.27%
2021 5.17%
2020 56.36%
2019 -1.89%
2018 11.38%

Continue Researching QGEN

Here are a few links from around the web to help you further your research on Qiagen Nv's stock as an investment opportunity:

Qiagen Nv (QGEN) Stock Price | Nasdaq
Qiagen Nv (QGEN) Stock Quote, History and News - Yahoo Finance
Qiagen Nv (QGEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8657 seconds.